0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 21-40 of 1710 Articles
JAMA Ophthalmology | 
Observation | 
Ah Ran Cho, MD; Young Hee Yoon, MD
JAMA Ophthalmol. 2016;134(4):463-464. doi:10.1001/jamaophthalmol.2015.5966.

JAMA Surgery | 
Original Investigation | 
Charles C. van Rossem, MD; Marc H. F. Schreinemacher, MD, PhD; Anna A. W. van Geloven, MD, PhD; et al.
JAMA Surg. 2016;151(4):323-329. doi:10.1001/jamasurg.2015.4236.
Includes: CME

JAMA Dermatology | 
Observation | 
Brittany G. Craiglow, MD; Daniel Tavares, PharmD; Brett A. King, MD, PhD
JAMA Dermatol. 2016;152(4):490-491. doi:10.1001/jamadermatol.2015.4445.

JAMA | 
Care of the Aging Patient: From Evidence to Action | 
Kasia J. Lipska, MD, MHS; Harlan Krumholz, MD, SM; Tacara Soones, MD, MPH; et al.
JAMA. 2016;315(10):1034-1045. doi:10.1001/jama.2016.0299.
Includes: CME, Supplemental Content

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(10):970. doi:10.1001/jama.2016.1780.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(9):861. doi:10.1001/jama.2016.1247.

JAMA Dermatology | 
Observation | 
Anita Hryncewicz-Gwóźdź, MD, PhD; Marta Wojciechowska-Zdrojowy, MD, PhD; Joanna Maj, MD, PhD; et al.
JAMA Dermatol. 2016;152(3):342-343. doi:10.1001/jamadermatol.2015.4293.

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(6):549. doi:10.1001/jama.2016.0003.

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(6):549. doi:10.1001/jama.2016.0162.

JAMA | 
Editorial | 
Jeffrey S. Gerber, MD, PhD
JAMA. 2016;315(6):558-559. doi:10.1001/jama.2016.0430.

JAMA | 
Original Investigation | 
Daniella Meeker, PhD; Jeffrey A. Linder, MD, MPH; Craig R. Fox, PhD; et al.
JAMA. 2016;315(6):562-570. doi:10.1001/jama.2016.0275.
Includes: CME, Supplemental Content

JAMA | 
From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2016;315(5):510-511. doi:10.1001/jama.2016.0048.

JAMA Dermatology | 
Observation | 
Roger Haber, MD; Alice Mouna Fayad, MD; Farid Stephan, MD; et al.
JAMA Dermatol. 2016;152(2):224-226. doi:10.1001/jamadermatol.2015.2939.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18729.

JAMA Dermatology | 
Observation | 
Ander Mayor-Ibarguren, MD; María Concepción Roldán-Puchalt, MD; Cristina Gómez-Fernández, MD; et al.
JAMA Dermatol. 2016;152(1):109-111. doi:10.1001/jamadermatol.2015.2702.

JAMA Dermatology | 
JAMA Dermatology Clinicopathological Challenge |  ONLINE FIRST
Pooja Chitgopeker, MD; Anthony J. Little, MD; Brian L. Swick, MD
JAMA Dermatol. Published online December 16, 2015. doi:10.1001/jamadermatol.2015.4232

JAMA Internal Medicine | 
Special Communication | 
Daniel J. Morgan, MD, MS; Sanket S. Dhruva, MD; Scott M. Wright, MD; et al.
JAMA Intern Med. 2015;175(12):1960-1964. doi:10.1001/jamainternmed.2015.5614.
Includes: CME

JAMA Oncology | 
From The JAMA Network | 
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Oncol. 2015;1(9):1340-1341. doi:10.1001/jamaoncol.2015.2274.

JAMA | 
Viewpoint |  FREE
Clay P. Wiske, MPhil, MBA; Oluwatobi A. Ogbechie, MD, MBA; Kevin A. Schulman, MD
JAMA. 2015;314(20):2129-2130. doi:10.1001/jama.2015.13498.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2015;314(20):2123. doi:10.1001/jama.2015.15665.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
News From the Food and Drug Administration  | 
New Fluoroquinolone Warning
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA
Viewpoint  | 
Medical Board Expectations for Physicians Recommending Marijuana
Humayun J. Chaudhry, DO, MS; Arthur S. Hengerer, MD; Gregory B. Snyder, MD